Abstract
Secondary chemotherapy adverse events are more frequent in elderly patients, due to functional decline of various organs, like liver, kidneys and pharmacodynamics changes consequent to water body reduction, comorbidities and concomitant medications for chronic diseases. Usually elderly patients with cancer are undertreated, despite several studies showing that these patients could have th…